Browse/search for people

Publication - Professor Tom Gaunt

    Metabolic Profiling of Adiponectin Levels in Adults

    Mendelian Randomization Analysis

    Citation

    Borges, MC, Barros, AJ, Ferreira, DLS, Casas, JP, Horta, BL, Kivimaki, M, Kumari, M, Menon, U, Gaunt, TR, Ben-Shlomo, Y, Freitas, DF, Oliveira, IO, Gentry-Maharaj, A, Fourkala, E, Lawlor, DA & Hingorani, AD, 2017, ‘Metabolic Profiling of Adiponectin Levels in Adults: Mendelian Randomization Analysis’. Circulation: Cardiovascular Genetics, vol 10.

    Abstract

    BACKGROUND: Adiponectin, a circulating adipocyte-derived protein, has insulin-sensitizing, anti-inflammatory, antiatherogenic, and cardiomyocyte-protective properties in animal models. However, the systemic effects of adiponectin in humans are unknown. Our aims were to define the metabolic profile associated with higher blood adiponectin concentration and investigate whether variation in adiponectin concentration affects the systemic metabolic profile.

    METHODS AND RESULTS: We applied multivariable regression in ≤5909 adults and Mendelian randomization (using cis-acting genetic variants in the vicinity of the adiponectin gene as instrumental variables) for analyzing the causal effect of adiponectin in the metabolic profile of ≤37 545 adults. Participants were largely European from 6 longitudinal studies and 1 genome-wide association consortium. In the multivariable regression analyses, higher circulating adiponectin was associated with higher high-density lipoprotein lipids and lower very-low-density lipoprotein lipids, glucose levels, branched-chain amino acids, and inflammatory markers. However, these findings were not supported by Mendelian randomization analyses for most metabolites. Findings were consistent between sexes and after excluding high-risk groups (defined by age and occurrence of previous cardiovascular event) and 1 study with admixed population.

    CONCLUSIONS: Our findings indicate that blood adiponectin concentration is more likely to be an epiphenomenon in the context of metabolic disease than a key determinant.

    Full details in the University publications repository